Live symbol workspace

AZN market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Current $171.61

Trend Flat

Sentiment Neutral

{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Detailed Market Analysis

Key Levels

Support

$163.03

Resistance

$180.19

Volume & Momentum

Volume

Weak

0.8x avg

Momentum

0%

Weak

Technical Context

Current price

$171.61

RSI context

50

Market Sentiment

50

Neutral

Stock Metrics

Daily Vol

0%

VIX Est

20

Weekly

0%

Asset Intelligence Dossier

Over the last 30 days, AI sentiment for AZN skewed neutral (2 of 3 scored calls).

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

30%

— 0.0 pts vs previous week

Avg confidence across 4 calls in the last 7 days

What sources say

Neutral 2 articles

US Stock Futures Flat After S&P500, Dow End At Record Highs On Strong Earnings, Easing Geopolitical Concerns — PLTR, AZN, CMG, MRNA In Focus

Tyson Falls on 3Q Results; Bristol-Myers Squibb Surges on Potential Acquisition | Stock Movers

Bullish 1 article

AstraZeneca holds talks with Bristol Myers Squibb on pharma megadeal

Insider Trading

Refreshing insider trades from FinViz…

Technical Observations

Refreshing technical observations from FinViz...

AZN News Intelligence (4 articles)

AI-curated news influencing AZN price, sentiment, and trend

Explore All AZN News with AI Analysis

Economy

2 weeks, 6 days ago

US Stock Futures Flat After S&P500, Dow End At Record Highs On Strong Earnings, Easing Geopolitical Concerns — PLTR, AZN, CMG, MRNA In Focus

President Donald Trump discussed efforts to de-escalate US-Iran tensions with Qatari Emir Tamim bin Hamad Al Thani.

Impact on AZN: Neutral market sentiment indicated

Analysis of stock market developments showing neutral sentiment. Medium (50%)

View full analysis →

Yahoo Finance 50% confidence

Economy

3 weeks, 1 day ago

Tyson Falls on 3Q Results; Bristol-Myers Squibb Surges on Potential Acquisition | Stock Movers

On this episode of Stock Movers: - Bristol-Myers Squibb (SQB) shares are surging on news AstraZeneca (AZN), whose shares are …

Impact on AZN: Neutral market sentiment indicated

Analysis of stock market developments showing neutral sentiment. Medium (50%)

View full analysis →

Bloomberg 50% confidence

Global Markets & Finance

3 weeks, 2 days ago

AstraZeneca holds talks with Bristol Myers Squibb on pharma megadeal

Tie-up would create one of the world’s biggest drugmakers

Impact on AZN: The news of a potential megadeal between AstraZeneca (AZN) and Bristol Myers …

AstraZeneca is in talks with Bristol Myers Squibb for a potential pharma megadeal, which could … High (80%)

View full analysis →

Financial Times 80% confidence

Stocks

1 month, 2 weeks ago

AstraZeneca's trial flop raises a bigger question: Is its pipeline premium becoming more vulnerable?

For years, AstraZeneca has commanded one of the richest valuations among large European pharma companies on the assumption that it …

Impact on AZN: The trial flop may lead to a decline in AstraZeneca's stock price, …

AstraZeneca's trial flop raises concerns about its pipeline premium, potentially impacting its valuation and the … High (80%)

View full analysis →

CNBC 80% confidence